Login / Signup

Comment on: "Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance".

Robert P GiuglianoRaffaele De CaterinaTakeshi Yamashita
Published in: Drug safety (2021)
Keyphrases
  • direct oral anticoagulants
  • interstitial lung disease
  • systemic sclerosis
  • venous thromboembolism
  • atrial fibrillation
  • adverse drug
  • rheumatoid arthritis
  • idiopathic pulmonary fibrosis
  • drug induced